Overview


According to FutureWise analysis the market for Ophthalmology Drugs and Devices is expected to register a CAGR of 6.00% from 2023-2031.

The branch of medicine that deals with the diagnosis and treatment of eye disorders is known as ophthalmology. Ophthalmic devices are used for cataract surgery, glaucoma surgery, and refractive surgery. The use of ophthalmic drugs is used to treat various eye diseases such as eye infections, glaucoma, and cataracts. Ophthalmology Drugs And Devices Market is witnessing a significant growth as a result of the rising incidence and prevalence of eye diseases like macular degeneration, presbyopia, and diabetic retinopathy among the aging population. Due to the advancement of ophthalmic devices equipped with advanced technologies, people are increasingly turning to ophthalmic surgery to treat their eye related problems.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Ophthalmology Drugs and Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Ophthalmology Drugs and Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Alcon
  • Allergan
  • Merck
  • Pfizer
  • Roche
  • Santen
  • Abbott Medical Optics
  • Alcon, Bausch & Lomb, Inc.
  • Carl Zeiss Meditec
  • Essilor
  • Johnson & Johnson
  • Nidek
  • Topcon

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Device

  • Diagnostic and monitoring devices
    • Optical Coherence Tomographers (OCT)
    • Ophthalmic ultrasound imaging systems
    • Fundus cameras
    • Ophthalmoscopes
    • Retinoscopes
    • Wavefront aberrometer
    • Corneal topographer
    • Autorefractors/Phoropters
    • Pachymeters
    • Keratometers
    • Specular microscopes
    • Biometers
    • Visual field analysers/Perimeter
    • Tonometers
    • Slit lamps
    • Optotype projectors
    • Dioptometers
  • Surgical devices
    • Cataract
      • Intraocular Lens (IOL)
      • Ophthalmic Viscoelastic Devices (OVD)
      • Phacoemulsification Devices
    • Glaucoma
      • Glaucoma Drainage Devices (GDD)
      • Stents and Implants
      • Glaucoma Lasers
      • Glaucoma Systems
    • Refractive error
      • Excimer Laser
      • YAG Laser
      • Microkeratome
      • Femtosecond Laser
    • Vitreoretinal
      • Vitrectomy Machines
      • Photocoagulation Lasers
      • Illumination Devices
  • Vision care
    • Contact lenses
    • Spectacles

By Drug

  • Glaucoma
  • Retinal disorders (Age-related Macular Degeneration (AMD), Diabetic retinopathy, Macular edema)
  • Dry eye
  • Allergy/Inflammation/Conjunctivitis

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Ophthalmology Drugs and Devices Market By Device, By Drug and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Ophthalmology Drugs and Devices Market Variables, Trends and Scope

    •     1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Ophthalmology Drugs and Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Ophthalmology Drugs and Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Ophthalmology Drugs and Devices Market, By Device Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Diagnostic and monitoring devices
         1.1. Optical Coherence Tomographers (OCT)
         1.2. Ophthalmic ultrasound imaging systems
         1.3. Fundus cameras
         1.4. Ophthalmoscopes
         1.5. Retinoscopes
         1.6. Wavefront aberrometer
         1.7. Corneal topographer
         1.8. Autorefractors/Phoropters
         1.9. Pachymeters
         1.10.Keratometers
         1.11.Specular microscopes
         1.12.Biometers
         1.13.Visual field analysers/Perimeter
         1.14.Tonometers
         1.15.Slit lamps
         1.16.Optotype projectors
         1.17.Dioptometers
        2. Surgical devices
         2.1. Cataract
          2.1.1. Intraocular Lens (IOL)
          2.1.2. Ophthalmic Viscoelastic Devices (OVD)
          2.1.2. Phacoemulsification Devices
         2.2. Glaucoma
          2.2.1. Glaucoma Drainage Devices (GDD)
          2.2.2. Stents and Implants
          2.2.3. Glaucoma Lasers
          2.2.4. Glaucoma Systems
         2.3. Refractive error
          2.3.1. Excimer Laser
          2.3.2. YAG Laser
          2.3.3. Microkeratome
          2.3.4. Femtosecond Laser
         2.4. Vitreoretinal
          2.4.1. Vitrectomy Machines
          2.4.2. Photocoagulation Lasers
          2.4.3. Illumination Devices
        3. Vision care
         3.1. Contact lenses
         3.2. Spectacles

  • 8.   Ophthalmology Drugs and Devices Market, By Drug Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Glaucoma
        2. Retinal disorders (Age-related Macular Degeneration (AMD), Diabetic retinopathy, Macular edema)
        3. Dry eye
        4. Allergy/Inflammation/Conjunctivitis

  • 9.   North America Ophthalmology Drugs and Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Ophthalmology Drugs and Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Ophthalmology Drugs and Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Ophthalmology Drugs and Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Alcon
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Allergan
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Merck
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Pfizer
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Roche
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Santen
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Abbott Medical Optics
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Alcon, Bausch & Lomb, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Carl Zeiss Meditec
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Essilor
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Johnson & Johnson
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Nidek
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Topcon
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact

    • 1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by administrations
      5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11